Inventor
Tacey X. Viegas
Inventor
Madison, AL, US
Overview
Patents· 47 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes36%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
C08GMacromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds9%
C08LCompositions of macromolecular compounds8%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests7%
A61FFilters implantable into blood vessels5%
A61LMethods or apparatus for sterilising materials or objects in general3%
C07KPeptides3%
C07CAcyclic or carbocyclic compounds2%
C07DHeterocyclic compounds2%
PatentTitleYear
11,129,794Chemically modified small molecules202111,065,340Polyoxazoline antibody drug conjugates202110,864,276Activated polyoxazolines and conjugates and compositions comprising the same202010,463,659Multi-arm polymer prodrugs201910,426,768Subcutaneous delivery of polymer conjugates of therapeutic agents201910,314,837Subcutaneous delivery of poly(oxazoline) polymer conjugates201910,166,294Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same201910,086,084Activated polyoxazolines and conjugates and compositions comprising the same201810,071,168Polyoxazoline antibody drug conjugates20189,808,533'Multi-arm polymer prodrugs'20179,388,104'Chemically modified small molecules'20169,333,200'Multi-arm polymer prodrugs'20169,107,956'Oligomer-protease inhibitor conjugates'20158,771,662'Multi-arm polymer prodrugs'20148,597,633'Subcutaneous delivery of poly(oxazoline) conjugates'20138,598,364'Oligomer-protease inhibitor conjugates'20138,580,919'Polymer conjugates of GLP-1'20138,501,899'Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same'20138,394,365'Multi-arm polymer prodrugs'20138,383,093'Subcutaneous delivery of poly(oxazoline) conjugates'20138,318,145'Multi-arm polymer prodrugs'20128,293,869'Polymer conjugates of GLP-1'20128,263,062'Multi-arm polymer prodrugs'20128,101,706'Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same'20128,067,431'Chemically modified small molecules'20118,034,825'Chemically modified small molecules'20117,786,133'Chemically modified small molecules'20107,744,861'Multi-arm polymer prodrugs'20106,497,157'Intrinsic dissolution apparatus with stationary sample holder'20026,346,272'Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels'20026,136,334'Medical uses of in situ formed gels'20005,958,443'Medical uses of in situ formed gels'19995,847,023'Thermal irreversible gel corneal contact lens formed in situ'19985,593,683'Method of making thermoreversible polyoxyalkylene gels'19975,587,175'Medical uses of in situ formed gels'19965,376,693'Thermo-irreversible gel corneal contact lens formed in situ'19945,346,703'Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels'19945,318,780'Medical uses of in situ formed gels'19945,306,501'Drug delivery by injection with thermoreversible gels containing polyoxyalkylene copolymers'19945,300,295'Ophthalmic drug delivery with thermoreversible polyoxyalkylene gels adjustable for pH'19945,298,260'Topical drug delivery with polyoxyalkylene polymer thermoreversible gels adjustable for pH and osmolality'19945,292,516'Body cavity drug delivery with thermoreversible gels containing polyoxyalkylene copolymers'19945,277,911'Ablatable mask of polyoxyalkylene polymer and ionic polysaccharide gel for laser reprofiling of the cornea'19945,143,731'Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels'19925,124,151'Drug delivery by injection with thermo-irreversible gels'19925,077,033'Ophthalmic drug delivery with thermo-irreversible gels of polxoxyalkylene polymer and ionic polysaccharide'19915,071,644'Topical drug delivery with thermo-irreversible gels'1991Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1991–1994Patents assigned to MEDIVENTURES INC (12)· patent assignee history
1991–1998Based in Ann Arbor, MI, US· patent location history
1994–1999Based in Canton, MI, US· patent location history
1996–2002Patents assigned to MDV TECH INC (6)· patent assignee history
2000–2002Based in Birmingham, AL, US· patent location history
2010–2021Patents assigned to NEKTAR THERAPEUTICS (17)· patent assignee history
2010–2021Based in Madison, AL, US· patent location history
2012–2021Patents assigned to SERINA THERAPEUTICS INC (11)· patent assignee history
2012–2013Patents assigned to VIEGAS TACEY X (6)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NEKTAR THERAPEUTICS | 17 | 2010–2021 |
| MEDIVENTURES INC | 12 | 1991–1994 |
| SERINA THERAPEUTICS INC | 11 | 2012–2021 |
| MDV TECH INC | 6 | 1996–2002 |
| VIEGAS TACEY Xself | 6 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Madison, AL, US | 28 | 2010–2021 |
| Ann Arbor, MI, US | 10 | 1991–1998 |
| Canton, MI, US | 6 | 1994–1999 |
| Birmingham, AL, US | 3 | 2000–2002 |